As an international leader in research and treatment of Neurofibromatosis (NF), we at the Washington University NF Center unite outstanding laboratory and clinical investigators, with expert clinicians to provide comprehensive treatment options for children and adults with these complex genetic conditions.
What We Treat
Here at the Center, we treat Neurofibromatosis (NF), a set of complex genetic disorders that affects nearly every organ system, causing tumors to grow in the brain and throughout the body. There are three distinct types of NF: neurofibromatosis type 1 (NF1), schwannomatosis, and neurofibromatosis type 2-schwannomatosis (NF2-schwannomatosis).
Integrating Research & Care: Our Mission
The mission of the Washington University NF Center is to translate groundbreaking research into exceptional patient care. Using an integrated approach, we combine innovative laboratory science with multidisciplinary clinical care and novel complementary care programs. The collective focus of these researchers and clinicians is directed toward developing and optimizing treatments for children and adults with NF.
Leading the Charge
Over the last decade, The Washington University NF Center has grown to become one of the largest and most comprehensive NF centers in the world. From research excellence to outstanding multidisciplinary patient care to integrative complementary care approaches, the NF Center is pushing the boundaries of what is possible for people affected with NF. Today, the Washington University NF Center is internationally recognized as one of the premier clinical and research programs focused entirely on NF.
